scholarly journals Use of the emergency department for less-urgent care among type 2 diabetics under a disease management program

2009 ◽  
Vol 9 (1) ◽  
Author(s):  
Shang-Jyh Chiou ◽  
Claudia Campbell ◽  
Ronald Horswell ◽  
Leann Myers ◽  
Richard Culbertson
2002 ◽  
Vol 95 (1) ◽  
pp. 78-87 ◽  
Author(s):  
IBRAHIM AWAD IBRAHIM ◽  
JEFF BEICH ◽  
JAAN SIDOROV ◽  
ROBERT GABBAY ◽  
LUCY YU

2021 ◽  
Vol 12 ◽  
pp. 215013272098440
Author(s):  
Firas Farisi Alkaff ◽  
Fauzan Illavi ◽  
Sovia Salamah ◽  
Wiwit Setiyawati ◽  
Ristra Ramadhani ◽  
...  

Background: Indonesia through its government National Health Insurance System has launched a non-communicable and chronic disease management program named Indonesian Chronic Disease Management Program (PROLANIS), with Type 2 Diabetes Mellitus (T2DM) and hypertension as the main focus. However, study that evaluates the clinical impact of PROLANIS in patients with T2DM is still scarce to this date. This study aims to evaluate the metabolic control and renal function of PROLANIS participants with T2DM every six month within the first 18-months of implementation. Methods: This study was a retrospective cohort study conducted at Wates sub-district, East Java using secondary data from PROLANIS group report from April 2018 to October 2019. The study population was T2DM patients who voluntarily joined the PROLANIS group in April 2018. The six-month-evaluation included metabolic parameters [body mass index (BMI), blood pressure, hemoglobin A1C, total cholesterol, high-density lipid, low-density lipid, and triglyceride (TG)] and renal parameters [blood urea nitrogen (BUN), creatinine serum, and urinary microalbumin]. Paired t-test and wilcoxon signed-rank test was used for the analysis, and the P-value was adjusted using Bonferroni correction. A P-value < .0015 was considered statistically significant, while a P-value between .0015 and .003 was considered as marginally significant. Results: A total of 30 participants were included in the analysis. Following the PROLANIS implementation, the only parameter of metabolic control that showed significant improvement was TG serum level ( P < .001). Despite the worsening status of other metabolic parameters, the changes were not statistically significant except for BMI that was marginally significant ( P = .002). From renal function, only BUN serum level was significantly deteriorated ( P < .001), while the others did not significantly change. Conclusion: PROLANIS implementation in our study population seems to be ineffective. Future study with more primary healthcare centers needs to be done to scrutinize the clinical impact of this program nationwide.


2012 ◽  
Vol 12 (1) ◽  
Author(s):  
Birgit Fullerton ◽  
Antje Erler ◽  
Boris Pöhlmann ◽  
Ferdinand M Gerlach

2010 ◽  
Vol 10 (1) ◽  
Author(s):  
Ingmar Schäfer ◽  
Claudia Küver ◽  
Benjamin Gedrose ◽  
Eike-Christin von Leitner ◽  
András Treszl ◽  
...  

F1000Research ◽  
2021 ◽  
Vol 10 ◽  
pp. 389
Author(s):  
Uriel Palacios-Barahona ◽  
Jaime Ordoñez Molina ◽  
Nelson Alvis Guzmán ◽  
José Fernando Botero Arango

Background: Type 2 diabetes is a significant cause of morbidity and mortality worldwide. The prevalence has increased due to population aging, obesity, and longer life expectancy. Likewise, the development of complications related to the disease has contributed to a more significant disease burden and is the leading cause of death in people with diabetes.  Methods: A descriptive study of patients in a disease management program in Medellín, Colombia, from June 10, 2014 to March 30, 2019 was carried out. Sociodemographic and clinical data were collected from clinical records. Descriptive analysis was performed using absolute and relative frequencies and the prevalences presented by sex. The Chi-square test was used to calculate the prevalence ratio with a 95 % confidence interval, with a p-value < 0.05 being considered statistically significant. Results: There were 1,018 patients with type 2 diabetes analyzed. The mean age was 66.0 years (SD: 12.93), the mean duration with diabetes was 12.9 years (SD:9.3), 55 % of patients were women, and 60.6 % of patients had no metabolic control. The main comorbidities were dyslipidemia in 67.9 %, obesity in 61.4 %, and hypertension in 59 % of patients. Differences were observed in the prevalence ratio (PR) of women versus men for dyslipidemia (PR 0.68 [CI: 0.52 - 0.89]), coronary artery disease (PR 0.41 [CI: 0.28 - 0,61]) and obesity (PR 0.23 [CI: 0.17 - 0.30]). Conclusions: Patients with type 2 diabetes have a high prevalence of comorbidities: dyslipidemia, obesity and arterial hypertension. A lower prevalence of comorbidities was observed in women than men for dyslipidemia, coronary heart disease, and obesity.


Sign in / Sign up

Export Citation Format

Share Document